Wuxi AppTec Co Ltd 02359
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 02359 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- HKD 35.20
- Day Range
- HKD 35.15–37.45
- 52-Week Range
- HKD 32.60–103.60
- Bid/Ask
- HKD 36.30 / HKD 36.35
- Market Cap
- HKD 106.48 Bil
- Volume/Avg
- 10.8 Mil / 10.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 9.01
- Price/Sales
- 2.34
- Dividend Yield (Trailing)
- 2.81%
- Dividend Yield (Forward)
- 2.81%
- Total Yield
- 2.97%
Company Profile
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Large Core
- Total Number of Employees
- 41,116
- Website
- https://www.wuxiapptec.com
Comparables
Valuation
|
Metric
|
02359
|
ACRS
|
300685
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.01 | — | 33.07 |
Price/Book Value | 1.72 | 0.54 | 4.85 |
Price/Sales | 2.34 | 2.66 | 7.85 |
Price/Cash Flow | 7.11 | — | 27.25 |
Price/Earnings
02359
ACRS
300685
Financial Strength
|
Metric
|
02359
|
ACRS
|
300685
|
|---|---|---|---|
Quick Ratio | 1.57 | 3.86 | 13.42 |
Current Ratio | 2.06 | 4.16 | 13.97 |
Interest Coverage | 59.83 | — | 194.63 |
Quick Ratio
02359
ACRS
300685
Profitability
|
Metric
|
02359
|
ACRS
|
300685
|
|---|---|---|---|
Return on Assets (Normalized) | 14.02% | −38.26% | 11.25% |
Return on Equity (Normalized) | 19.29% | −50.08% | 12.34% |
Return on Invested Capital (Normalized) | 16.81% | −49.93% | 12.20% |
Return on Assets
02359
ACRS
300685
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Yrvbcnvy | Wvc | $209.3 Bil | |
DHR
| Danaher Corp | Mxcmfkzdrl | Cbkjvz | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Lldrdkyzl | Hrtpxp | $42.8 Bil | |
IDXX
| IDEXX Laboratories Inc | Rstljkcz | Nsmgy | $41.5 Bil | |
A
| Agilent Technologies Inc | Lsrmxscgrl | Yht | $40.4 Bil | |
MTD
| Mettler-Toledo International Inc | Hwkxtgsd | Dkmzsm | $26.5 Bil | |
ICLR
| Icon PLC | Kvmtzkh | Pjjbsj | $24.8 Bil | |
ILMN
| Illumina Inc | Ycgsmjx | Mdprcc | $19.5 Bil | |
WAT
| Waters Corp | Qzrhxtcn | Tgkn | $18.5 Bil | |
LH
| Laboratory Corp of America Holdings | Jsprcswwf | Xrdmrmv | $16.7 Bil |